New in @eLife by the @versteegga lab w/ first author @SaraScini! TTP is a critical player in the resolution of the inflammatory response. The team identified HUWE1 as a strong regulator of TTP proteasomal degradation. Read more: https://t.co/AZh0nwJx6H @univienna
Dr. Michael Bauer takes over as new Chief Executive Officer of QUANTRO.
Michael is a seasoned biotech entrepreneur, with the right set of skills to realize the potential of our platform and drive our growth even further.
Welcome Michael!
Read more - PR: https://t.co/IfOHBdzucC
Our paper on how the E3 ligase HUWE1 controls the degradation of one of the main cellular inflammation inhibitors -TTP- is out in @eLife. Fantastic efforts of @sarascini, in collaboration with the labs of @clausen_lab, Pavel Kovarik, and
@johannes_zuber. https://t.co/ZbD8v3ORSc
Check out our latest preprint from Milica Vunjak et al. in collaboration with the labs of @johannes_zuber and Thomas Decker! We describe how the E3 ligase SPOP recognizes conserved degrons in the immune TF IRF1, and targets it for proteasomal degradation. https://t.co/GqjLsCdFha
Excited to share our latest prep-print by @sarascini and the labs of @clausen_lab, Pavel Kovarik, and @johannes_zuber! Check out how the E3 ligase HUWE1 controls the proteasomal degradation of one of the main negative regulators of inflammation, TTP. https://t.co/iabs9JL395